GenVault

What GenVault does

GenVault is a privately held, GxP-compliant biorepository service provider operating from a purpose-built, five-floor facility of over 500,000 sq.ft. in West Deptford, New Jersey. The company stores temperature-sensitive biological and pharmaceutical materials across the full spectrum from ambient (15-30°C) through controlled room temperature, refrigerated (2-8°C), -20°C and -80°C ultra-low, to vapor-phase liquid nitrogen cryogenic storage (-150°C to -196°C), with stated capacity for more than 150 million samples. Service tiers include dedicated biorepository storage, ICH-compliant stability chambers for shelf-life and accelerated stability studies, and GenVault Transport Services (GTS), an integrated cold-chain logistics division operating custom 40-foot tractor-trailers for nationwide lab relocations, cryogenic freezer transport, high-value equipment moves, and HAZMAT-compliant chemical transport. The underlying technology stack combines a cloud-based LIMS with API integration for client system connectivity, Rees environmental monitoring with hard-wired dual sensors and multi-channel alarm notifications, redundant power infrastructure (diesel and natural gas generators plus a 6,000-gallon LN2 reserve supporting 14 days of autonomous operation), and physical security architecture including facial recognition, ESFR fire suppression, and 12-inch impermeable precast walls.

The company is accredited to ISO 9001:2015 and ISO 20387 (A2LA), holds CAP Biorepository Accreditation, is FDA registered as a 3PL and HCT/P establishment, and operates in full compliance with 21 CFR Part 11 and GxP guidelines. GenVault serves pharmaceutical, biotechnology, cell and gene therapy, CDMO/CRO, research institution, university, government, healthcare, and foundation customers. Revenue is generated through quote-driven, multi-year subscription contracts for storage (per-unit or per-space, across temperature tiers), project-based transport engagements, and ancillary managed services (intake processing, barcode registration, retrieval, aliquoting, sample audits, and API-based integration). The go-to-market motion is direct enterprise field sales supported by thought leadership content, white papers, benchmark studies, and event presence (World Vaccine Congress, Alexandria LaunchLabs). The company was founded by the leadership behind DocuVault, a records management business with over 20 years of experience in secure storage of sensitive government, healthcare, and cultural assets. Strategic partnerships include Diligent Pharma (vendor qualification, October 2024) and Blood Cancer United (CSR/sponsorship, 2025).

Name

GenVault

Legal name

GenVault

Website

https://genvault.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

GenVault is a privately held, GxP-compliant biorepository operator providing temperature-controlled storage (ambient to cryogenic), ICH stability chambers, and integrated cold-chain transport services from a 500,000+ sq.ft. West Deptford, NJ facility serving pharmaceutical, biotech, CDMO/CRO, and research institution clients.

Ownership category

akta.pro rank

Product category

Biorepository Services

NAICS

Refrigerated Warehousing and Storage (493120)

SIC

Refrigeration & Service Industry Machinery (3580)

akta.pro primary industry

GxP Warehousing, Storage & Distribution (ambient + controlled) (HLAGAMAH)

akta.pro secondary industries

Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Pharmaceutical & Life Sciences Cold Chain Storage (2–8°C / CRT) (TLALABAF), Biologics, Vaccines & Ultra-Low Temperature (ULT) Storage (TLALABAG), Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN)

Keywords

• Biorepository storage services
• Sample management solutions
• Cold chain logistics
• Cryogenic sample storage
• GxP compliant storage

Headquarters

HQ city

Carlsbad

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Infrastructure, Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Biorepository Sample Storage Services: GenVault's primary revenue stream derives from providing GxP-compliant, temperature-controlled storage across ambient, controlled room temperature, cold room (2–8°C), freezer (-20°C), ultra-low temperature (-80°C), and cryogenic (-150°C to -196°C) environments. Storage is offered on a per-unit or per-space basis with quote-driven pricing. The company offers promotional incentives (e.g., waived storage fees through 2026, free retrieval) to attract large-scale sample consolidations (50,000+ samples). Long-term client relationships are a key revenue driver, supported by the company's stated transparent pricing model with no surprise fees.
2. Stability Chamber Storage Services: Dedicated ICH-compliant stability chamber storage services for long-term and accelerated stability protocols, shelf-life studies, and GMP-regulated research. Offered as a standalone storage-only service, complementing the core biorepository offering and providing long-term contract revenue.
3. GenVault Transport Services (GTS) – Laboratory Relocation and Cold Chain Logistics: Specialized cold-chain transport services including biological material relocation, cryogenic freezer moves, high-value equipment moves, and laboratory chemical transportation. Services include pre-move assessment, logistics planning, monitored transportation via custom trucks, and delivery/installation. Revenue is project-based per move, with dedicated project managers, chemists, and HazMat-trained crews. The fleet covers local, regional, and cross-country relocations for academia, biotech, pharma, government, and clinical research organizations.
4. Sample Management and Value-Added Services: Additional services including intake processing, barcode registration, sample retrieval and return, data management via LIMS, program management (sample audits, aliquoting, shipping logistics coordination), secure sample destruction via third-party partner, and API-based system integration. These services complement storage and generate additional per-incident or per-project revenue.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels9 records

Core offering

GenVault operates a GxP-compliant biorepository providing temperature-controlled sample storage and management across ambient, controlled room temperature (CRT), cold room (2–8°C), freezer (-20°C), ultra-low temperature (-80°C), and cryogenic (-150°C to -196°C) environments, supporting pharmaceutical, biotech, clinical trial, research, and government clients. The company also offers ICH-compliant stability chamber storage and an integrated GenVault Transport Services (GTS) division for temperature-controlled laboratory relocations.

Product overview

GenVault is a GxP-compliant biorepository offering a unified suite of sample storage and management services. The core portfolio centers on Sample Management (Ambient & CRT, Cold Room, Freezer & ULT, and Cryogenic Storage) and Stability Chamber storage for ICH-compliant studies. Supporting these is GenVault Transport Services (GTS) for temperature-controlled lab relocations covering biological materials, cryogenic freezers, high-value equipment, and lab chemicals. A cloud-based LIMS provides real-time inventory tracking, environmental monitoring, and API-based integration with customer systems. The five-floor, 500,000+ sq.ft. facility can store more than 150 million samples across all temperature ranges.

Differentiator

Problem solved

Functional benefit

Products and services

• Ambient & CRT Storage

Quantifiable outcome

• 500,000+ cu.ft. of storage space and 150,000,000+ sample capacity across 5 temperature ranges in a single facility.
• +6 more outcomes

Named customers8 records

Segments8 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Two partnerships are on record, tiered minor and core.

• Blood Cancer United (Light The Night)minorGTM or Marketing Partner · 1 January 2025GenVault is a sponsor of Blood Cancer United's Light The Night campaign, which brings together families, survivors, and supporters to honor those impacted by blood cancer and fund life-saving research. GenVault donates a percentage of new collaborations directly to Blood Cancer United. As part of this CSR partnership, organizations connected through Blood Cancer United can access preferred rates on GenVault's sample storage services. This initiative combines charitable giving with a referral-driven GTM component.
• Diligent PharmacoreStrategic or Co-development Partner · 1 October 2024GenVault has partnered with Diligent Pharma, a company renowned for quality and risk management expertise in the clinical trial industry. Following Diligent Pharma's detailed audit process, GenVault's operations were validated against the highest standards of global regulatory requirements and industry best practices. The partnership streamlines onboarding processes and aligns GenVault with Diligent's advanced approach to vendor qualification, benefiting shared clients and partners. Joint thought leadership includes a quality management conversation featuring both companies' Head of Quality (Heather Olsen at GenVault and Anthea Dransfield at Diligent Pharma), published in December 2025.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Precision for Medicine: Precision for Medicine offers integrated biorepository, biospecimen management, and central lab services to biopharma sponsors and clinical research programs—competing with GenVault's pharmaceutical and CDMO/CRO segments with similar GxP/ICH-compliance positioning.
• Cryoport Systems: Cryoport provides cryogenic logistics, bioservices, and biostorage focused on the cell & gene therapy market—directly overlapping with GenVault's vapor-phase LN2 storage and GTS refrigerated transport offerings, with particular overlap in ultra-low temperature CGT logistics.
• Azenta Life Sciences (formerly Brooks Life Sciences): Azenta is the largest dedicated biorepository and cold-chain sample management provider globally, offering ambient-to-cryogenic storage, automated biobanking, and integrated lab relocation services to pharma, biotech, and academic clients—directly competing with GenVault across nearly every sample management and transport capability.
• LabConnect: LabConnect provides central laboratory, biospecimen management, and biorepository services for clinical trials and translational research—comparable to GenVault in serving pharma/CROs with regulated sample storage, kit manufacturing, and chain-of-custody logistics.
• Sampled: Sampled operates a federated biorepository network (formerly RUCDR, Infinity Biologix, BioStorage Technologies legacy assets) providing biospecimen storage, processing, and analytical services for pharma, biotech, and population genomics customers—comparable to GenVault in service breadth and target customers.
• BioStorage Technologies (a Thermo Fisher Scientific brand): BioStorage Technologies, now part of Thermo Fisher Scientific, provides global GxP-compliant sample storage, biobanking, and biospecimen management to pharma and CROs—competing head-on with GenVault's biorepository offering, and leveraging Thermo Fisher's broader scientific services portfolio as a differentiator.
• Inotiv: Inotiv (Envigo + RMS) operates preclinical research services alongside biobanking and biorepository offerings for academic, government, and pharma clients—comparable to GenVault in regulated biological sample storage and lifecycle services.

Broad incumbents

• Eurofins Scientific: Eurofins is a global life sciences testing services conglomerate whose bioanalytical, central lab, and biopharma services portfolios include biorepository and sample management capabilities; it competes with GenVault on enterprise pharma contracts but as part of a much broader testing/services portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/watch?v=U9HDbMo2Ecg
• LinkedInlinkedin.com/company/genvault

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds7 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenVault